{"id":"W4308103403","doi":"10.1016/j.jchromb.2022.123518","title":"Quantitation of cystic fibrosis triple combination therapy, elexacaftor/tezacaftor/ivacaftor, in human plasma and cellular lysate","year":2022,"lang":"en","type":"article","venue":"Journal of Chromatography B","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Center for Clinical and Translational Science, University of Alabama at Birmingham; National Institutes of Health; Choquette Family Foundation; Cystic Fibrosis Foundation","keywords":"Chemistry; Chromatography; Formic acid; Protein precipitation; Analyte; Selected reaction monitoring; Tandem mass spectrometry; Liquid chromatography–mass spectrometry; Ivacaftor; Mass spectrometry; Biochemistry; Cystic fibrosis transmembrane conductance regulator","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005256983,0.0006163994,0.0004119447,0.0005648895,0.0003211015,0.0004919516,0.0002847405,0.0006006271,0.001550899],"category_scores_gemma":[0.000720102,0.0001528043,0.0002669073,0.000503224,0.0002277489,0.0002311564,0.0001566344,0.0006660196,0.0007524202],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002751304,"about_ca_system_score_gemma":0.0004846044,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001082971,"about_ca_topic_score_gemma":0.001456016,"domain_scores_codex":[0.999461,0.0001707247,0.00003570801,0.000100745,0.0001486381,0.00008307944],"domain_scores_gemma":[0.9997397,0.00008125879,0.00003045563,0.00004695446,0.00005039794,0.00005111022],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002331913,0.0002665045,0.002621435,0.00006875752,0.00006847393,0.0001162688,0.000073638,0.0001956076,0.9840595,0.0001333183,0.0003989815,0.009665621],"study_design_scores_gemma":[0.000135348,0.002104301,0.01957696,0.0000274757,0.00008422299,0.0008752324,0.00007812519,0.00501755,0.9687835,0.00009035851,0.003212343,0.00001465649],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9738871,0.008982532,0.01058576,0.0003856931,0.0003395189,0.0001358187,0.001469186,0.0004087039,0.003805697],"genre_scores_gemma":[0.9756792,0.001880573,0.01097545,0.0002658496,0.0001227401,0.0001692972,0.003336448,0.00003914355,0.007531289],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001550899,"threshold_uncertainty_score":0.005188346,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01558847886735122,"score_gpt":0.2918502802108601,"score_spread":0.2762618013435089,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}